You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Neuroendocrine tumours (NET)

Showing 1 - 25 of 2,486
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Neuroendocrine Tumours (NET), Neuroendocrine Carcinomas (NEC) Trial in Spain (177Lu-Dotatate, Nivolumab)

Recruiting
  • Neuroendocrine Tumours (NET)
  • Neuroendocrine Carcinomas (NEC)
  • Santiago De Compostela, Galicia, Spain
  • +4 more
Aug 1, 2022

United Kingdom Patient Preference Study of Somatuline Autogel

Completed
  • Neuroendocrine Tumours (NET)
    • Birmingham, United Kingdom
    • +4 more
    Jul 5, 2022

    Neuroendocrine Tumours, Neuroendocrine Tumour of the Lung, Small Intestinal NET Trial in Worldwide (Surufatinib)

    Recruiting
    • Neuroendocrine Tumours
    • +2 more
    • Atlanta, Georgia
    • +18 more
    Mar 10, 2022

    Neuroendocrine Tumors Metastatic to the Liver Trial in Woodville (Rose bengal disodium)

    Unknown status
    • Neuroendocrine Tumors Metastatic to the Liver
    • Rose bengal disodium
    • Woodville, South Australia, Australia
      The Queen Elizabeth Hospital
    Oct 6, 2020

    Gastroenteropancreatic Neuroendocrine Tumours

    Recruiting
    • Gastroenteropancreatic Neuroendocrine Tumor
    • 68Ga-DOTATOC PET as a part of their clinical diagnostic work-up will be included
    • Milano, Italy
      Irccs San Raffaele
    Nov 24, 2023

    Neuroendocrine Tumors Trial in Innsbruck (68Ga-DOTA-MGS5)

    Completed
    • Neuroendocrine Tumors
    • Innsbruck, Austria
      Department of Nuclear Medicine, Medical University of Innsbruck
    Nov 24, 2023

    Neuroendocrine Tumors, Neuroendocrine Tumor of the Lung, Neuroendocrine Tumor Grade 1 Trial in Iowa City ([212Pb] VMT-a-NET,

    Recruiting
    • Neuroendocrine Tumors
    • +4 more
    • [212Pb] VMT-α-NET
    • [203Pb] VMT-α-NET SPECT/CT
    • Iowa City, Iowa
      Holden Comprehensive Cancer Center at the University of Iowa
    Nov 30, 2023

    Mobile Application to Collect PRO Data in NET Patients

    Recruiting
    • Neuroendocrine Neoplasms (Tumours)
      • London, United Kingdom
        King's College Hospital
      Nov 5, 2020

      Development of New Personalised 3D Preclinical Models of

      Recruiting
      • Pancreatic Neuroendocrine Tumor
        • Milan, MI, Italy
          IRCCS San Raffele Institute
        Nov 2, 2023

        Collect Somatuline® Injector Device Preferences of Patients

        Not yet recruiting
        • Neuroendocrine Tumors
          • (no location specified)
          Jun 19, 2023

          Quality of Life and Tolerance of Patients Treated With

          Not yet recruiting
          • Metastatic Neuroendocrine Tumour
            • Lyon, France
              Hospices Civils de Lyon, Hopital Lyon Sud
            Sep 12, 2023

            Neuroendocrine Tumor Grade 2, Neuroendocrine Tumor Grade 1 Trial ([203Pb]VMT-a-NET, SPECT/CT)

            Enrolling by invitation
            • Neuroendocrine Tumor Grade 2
            • Neuroendocrine Tumor Grade 1
            • Iowa City, Iowa
              The University of Iowa
            Dec 9, 2022

            HRQoL During PRRT in Patients With NETs

            Completed
            • Neuroendocrine Tumors
            • +2 more
              • (no location specified)
              Jun 16, 2022

              Neuroendocrine Tumors, Neuroendocrine Tumor of the Lung, Neuroendocrine Tumor of Pancreas Trial in Iowa City, Rochester

              Not yet recruiting
              • Neuroendocrine Tumors
              • +8 more
              • Iowa City, Iowa
              • +1 more
              Nov 23, 2022

              68Ga-HA-DOTATATE PET/CT in Adults With Neuroendocrine Tumors

              Recruiting
              • Neuroendocrine Tumors (NET)
              • 68Ga-HA-DOTATATE PET/CT imaging
              • Calgary, Alberta, Canada
                Foothills Medical Center 1403 29 St NW
              Jan 4, 2023

              Gastroenteropancreatico Tumors, Neuroendocrine Tumors, Neuroendocrine Tumors Trial run by the National Cancer Institute (NCI)

              Recruiting
              • Gastroenteropancreatico Tumors
              • +2 more
              • Bethesda, Maryland
                National Institutes of Health Clinical Center
              Jan 19, 2023

              DOTATOC PET/CT for Imaging NET Patients

              Recruiting
              • Neuroendocrine Tumors
              • +15 more
              • 68Ga-DOTATOC PET/CT
              • 18F-FDG PET/CT
              • Vancouver, British Columbia, Canada
                BC Cancer
              Nov 2, 2022

              Metastatic Midgut Neuroendocrine Tumor, Unresectable Midgut Neuroendocrine Tumor Trial (procedure, drug, other)

              Not yet recruiting
              • Metastatic Midgut Neuroendocrine Tumor
              • Unresectable Midgut Neuroendocrine Tumor
              • Biospecimen Collection
              • +5 more
              • (no location specified)
              Mar 16, 2023

              Neuroendocrine Tumor of Pancreas, Multiple Endocrine Neoplasia Type 1 Trial in Utrecht (High-dose-high precision MR-guided

              Recruiting
              • Neuroendocrine Tumor of Pancreas
              • Multiple Endocrine Neoplasia Type 1
              • High-dose-high precision MR-guided radiotherapy
              • Utrecht, Netherlands
                UMC Utrecht
              May 29, 2022

              Small Cell Lung Carcinoma (SCLC), Neuroendocrine Tumors Trial (BI 764532, [89Zr]Zr-BI 764532)

              Not yet recruiting
              • Small Cell Lung Carcinoma (SCLC)
              • Neuroendocrine Neoplasms
              • BI 764532
              • [89Zr]Zr-BI 764532
              • (no location specified)
              Jul 31, 2023

              68Ga-DOTATOC Radio-Guided Surgery With ß-Probe in GEP-NET

              Recruiting
              • Neuroendocrine Tumor Carcinoid
              • +2 more
                • Milan, Italy
                  IRCCS Istituto Europeo di Oncologia S.r.l.
                Jul 8, 2022

                Pancreatic Neuroendocrine Tumor Trial in Milano (peptide receptor radionuclide therapy with Y-90-DOTATOC)

                Recruiting
                • Pancreatic Neuroendocrine Tumor
                • peptide receptor radionuclide therapy with Y-90-DOTATOC
                • Milano, Italy
                • +1 more
                Sep 30, 2022

                Bronchial and Thymic Neuroendocrine Tumour, Paraganglioma/ Phaeochromocytoma, Medullary Thyroid Carcinoma Trial (Lu-177 DOTATATE

                Not yet recruiting
                • Bronchial and Thymic Neuroendocrine Tumour
                • +3 more
                • Lu-177 DOTATATE (Lutathera®)
                • (no location specified)
                Nov 1, 2023

                Small Cell Lung Cancer (SCLC), Large Cell Neuroendocrine Cancer (LCNEC), Neuroendocrine Prostate Cancer (NEPC) Trial (PT217)

                Not yet recruiting
                • Small Cell Lung Cancer (SCLC)
                • +3 more
                • (no location specified)
                Dec 7, 2022

                Neuroendocrine Tumors Trial in Edegem, Sint-Niklaas, Nicosia (Liquid biopsies, Scans (CT, gallium-68 DOTATE/TOC/NOC PET-CT))

                Recruiting
                • Neuroendocrine Tumors
                • Liquid biopsies
                • Scans (CT, gallium-68 DOTATE/TOC/NOC PET-CT)
                • Edegem, Antwerp, Belgium
                • +2 more
                Feb 24, 2022